1Williams MH,Handler CE,Akram R,et al.Role of Nterminal brain natriuretie peptide(NT-proBNP) in scleroderma-associated pulmonary arterial hypertension.Heart J,2006,27:1485-1494.
2Torbicki A,Kurzyna M,Kuca P,et al.Detectable serum cardiac troponin T as a marker of poor prognosis among patients with chronic precapillary pulmonary hypertension.Circulation,2003,108:844-848.
4Kawut SM,Hom EM,Berekashvili KK,et al.Von willebrand factor independently predicts long-term survival in patients with pulmonary arterial hypertension.Chest,2005,128:2355-2362.
5Elliott CG,Glissmeyer EW,Havlena GT,et al.Relationship of BMPR2 mutations to vnsorenctivity in pulmonary arterial hypertension.Circulation,2006,113:2509-2515.
6D'Alonzo GE,Barst RJ,Ayres SM,et al.Survival in patients with primary pulmonary hypertension:results from a national prospective registry.Ann Intern Med,1991,115:343-349.
7Jing ZC,Xu XQ,Han ZY,et al.Registry and survival study in chinese patients with idiopathic and familial pulmonary arterial hypertension.Chest,2007,132:373-379.
8McLanghlin VV,Presberg KW,Doyle RL,et al.Prognosis of pulmonary arterial hypertension.ACCP Evidence-based clinical practice guidelines.Chest,2004,126:78-92.
9Humbert M,Sitbon O,Chaouat A,et al.Pulmonary arterial hypertension in France results from a national registzy.Am J Respir Crit Care Med,2006,173:1023-1030.
10Cenedese E,Speich R,Dorschner L,et al.Measurement of quality of life in pulmonary hypertension and its significance.Ear Respir J,2006,28:808-815.
